Development of a Predictive Model for the Risk of Myelosuppression in Patients With Nasopharyngeal Carcinoma Undergoing Chemoradiotherapy.

Background: Myelosuppression is a frequent complication in patients with nasopharyngeal carcinoma (NPC) undergoing chemoradiotherapy. Current clinical practice relies predominantly on treatment-phase monitoring for myelosuppression risk assessment, while effective pretreatment prediction tools are l...

Full description

Bibliographic Details
Published in:Clinical Medicine Insights: Oncology Vol. 19; pp. 1 - 16
Main Authors: Wang, Ruo-han, Jiang, De-yue, Lu, Jin, Xun, Li-xue, Wang, Fan, Shao, Qian-qian, Zhang, Hao-xuan
Format: research tables/charts Journal Article
Published: Sage Publications Inc. 9/30/2025
Online Access:View this record in EBSCOhost